Appeal over decision to deny funding for rare disease?

Wednesday, 14 September 2011, 10:00 am | NZORD

Three patient advocacy groups have won a concession from Pharmac who will consider at their 27 September board meeting an appeal against their earlier decision to decline funding for Myozyme, a specialised enzyme replacement therapy. Myozyme treats Pompe ... More >>